From: Comparison of methacholine and mannitol challenges: importance of method of methacholine inhalation
 | MCH method | Definition of positive MCH | Asthma | Asthma | Non Asthma | Non Asthma | ||||
---|---|---|---|---|---|---|---|---|---|---|
MCH +ve | MCH total | MAN +ve | MAN total | MCH +ve | MCH total | MAN +ve | MAN total | |||
1 | DeVilbiss 40 | PD20 ≤ 7.8 μmola | 25 | 25 | 25 | 25 |  |  |  |  |
2 | Nebicheck Dosimeter | PD20 ≤ 8.0 μmola |  |  |  |  | 16 | 16 | 1 | 16 |
3 | Mefar dosimeter | PD20 ≤ 2 mga–10.2 μmol | 9 | 11 | 12 | 13 | 7 | 86 | 3 | 86 |
4 | Nebicheck Dosimeter | PD20 ≤ 8.0 μmola | 43 | 53 | 43 | 53 |  |  |  |  |
5 | ATS Dosimeter | PC20 ≤ 16 mg/mL | 122 | 240 | 132 | 240 | 34 | 135 | 36 | 135 |
6 | Mefar dosimeterb | PD20 ≤ 2 mga–10.2 μmol | 22 | 48 | 22 | 48 |  |  |  |  |
7 | Spira dosimeter | PD20 ≤ 8.0 μmola | 18 | 42 | 17 | 42 | 15 | 193 | 14 | 193 |
8 | Spira dosimeter | PD20 ≤ 8.0 μmola | 35 | 51 | 30 | 51 | 37 | 187 | 3 | 187 |
9 | Spira dosimeter | PC20 ≤ 16 mg/mL | 9 | 11 | 10 | 11 | 0 | 17 | 0 | 17 |
10 | Mefar dosimeter | PC20 ≤ 8 mg/mL | 74 | 123 | 76 | 123 |  |  |  |  |
11 | Chai dosimeter | PC20 ≤ 16 mg/mL | 22 | 50 | 24 | 50 | 1 | 54 | 4 | 54 |
12 | Jaeger dosimeter | PD20 ≤ 7.8 μmola | 79 | 122 | 46 | 122 | 32 | 68 | 11 | 68 |
13 | Spira dosimeter | PC20 ≤ 16 mg/mL | 90 | 134 | 100 | 134 |  |  |  |  |
 | Total % |  | 548 60.2% | 910 | 537 58.9% | 912 | 142 18.8% | 756 | 72 9.5% | 756 |
 | Exclude studies 1, 2 and 9 Total % |  | 514 58.8% | 874 | 502 57.3% | 876 | 126 17.4% | 723 | 71 9.8% | 723 |